cp wire

CP Wire Articles

Kite Receives Positive Opinion from CHMP for Yescarta in Lymphoma



Kite, a Gilead Company (Nasdaq: GILD) announced on 6/29/2018 that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion... read more

Fri, 06/29/18 - 09:42 am
Argenx Receives Milestone Payment from AbbVie for Preclinical Oncology Drug

Argenx (Euronext & Nasdaq: ARGX) announced on 6/28/2018 the achievement of the second of two preclinical milestones towards... read more

Thu, 06/28/18 - 09:57 am
Arsanis Discontinues Ph II Trial of ASN100

Arsanis, Inc. (NASDAQ:ASNS) announced on 6/28/2018 the discontinuation of its Phase 2 clinical trial of ASN100 for the prevention of S. aureuspneumonia in high-risk, mechanically ventilated... read more

Thu, 06/28/18 - 09:43 am
$1.3 Billion Merger Between Akebia Therapeutics and Keryx Biopharmaceuticals to Focus on Kidney Disease
  • Combined company will be named Akebia Therapeutics, Inc.
  • Company will focus on patients with chronic kidney disease
  • Combined portfolio can address the needs of an estimated... read more
Thu, 06/28/18 - 09:17 am
Cedilla Therapeutics Adds Three Veterans to Enhance Discovery

Cedilla Therapeutics  announced on 6/28/2018 the appointment of three vice presidents with extensive experience in drug discovery to advance the company’s mission of harnessing existing protein... read more

Thu, 06/28/18 - 09:05 am

Pages